MetrioGene BioSciences was a Montreal-based biotechnology company focused on advancing diagnostic and therapeutic solutions for endometriosis. As a specialized subsidiary of Procrea BioSciences, the company stood out for its innovative preclinical models and its work in identifying blood-based biomarkers.
